• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Common Muscle Relaxant Baclofen Could Pose Mental Dangers for Seniors
SATURDAY, Nov. 9, 2019 -- A commonly prescribed muscle relaxant known as baclofen can leave older kidney patients so disoriented that they land in the hospital, a new study warns. " It can present with acute stroke-like symptoms, even though it ' s...
Source: Drugs.com - Daily MedNews - November 9, 2019 Category: General Medicine Source Type: news

Common Muscle Relaxant, Baclofen, Could Pose Mental Dangers for Seniors
SATURDAY, Nov. 9, 2019 -- A commonly prescribed muscle relaxant known as baclofen can leave older kidney patients so disoriented that they land in the hospital, a new study warns. " It can present with acute stroke-like symptoms, even though it ' s...
Source: Drugs.com - Daily MedNews - November 9, 2019 Category: General Medicine Source Type: news

Common Muscle Relaxant Could Pose Mental Dangers for Seniors
SATURDAY, Nov. 9, 2019 -- A commonly prescribed muscle relaxant known as baclofen can leave older kidney patients so disoriented that they land in the hospital, a new study warns. " It can present with acute stroke-like symptoms, even though it ' s not...
Source: Drugs.com - Daily MedNews - November 9, 2019 Category: General Medicine Source Type: news

New Partnership Forms to Develop Breakthrough Neuromodulation Device
WeHealth, an e-health department of Servier Group, said it is in a partnership with Pathmaker Neurosystems, a pioneering clinical-stage bioelectronic medicine company. The two companies revealed plans to develop and commercialize the first neuromodulation technology designed to treat muscle spasticity non-invasively. The new technology will be known as the MyoRegulator device. The new MyoRegulator PM-200 provides a non-invasive treatment option for patients suffering from muscle spasticity, a common condition found in many patients suffering from stroke, cerebral palsy, multiple sclerosis, spinal cord injury, and traumatic...
Source: MDDI - March 26, 2019 Category: Medical Devices Authors: Kristopher Sturgis Tags: Business Source Type: news

Baclofen Toxicity Causing Acute, Reversible Dyskinesia.
Abstract The following unique case demonstrates an episode of acute dyskinesia secondary to oral baclofen toxicity. We discuss an 80-year-old man with a history of Stage III chronic kidney disease, coronary artery disease, diabetes and stroke who presented to the Emergency Department with new onset of behavioral changes and irregular jerking movements. The patient had been recently prescribed baclofen 10mg twice daily for a back strain he suffered; he subsequently was admitted to the hospital, and his symptoms resolved within 48 hours of admission and discontinuance of baclofen. PMID: 27234296 [PubMed - as supplied by publisher]
Source: Journal of Medical Toxicology - May 26, 2016 Category: Toxicology Authors: Niehaus MT, Elliott NC, Katz KD Tags: J Med Toxicol Source Type: research